# Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda - 2012

> **NCT01730313** · PHASE2 · WITHDRAWN · sponsor: **Centers for Disease Control and Prevention**

## Conditions studied

- Nodding Syndrome

## Interventions

- **DRUG:** Pyridoxine
- **DRUG:** Sodium Valproate
- **DRUG:** Phenytoin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01730313
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-02
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Did not get approval from the collaborating partners in-country
- **Last updated:** 2022-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01730313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01730313, "Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda - 2012". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01730313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*